All lobbying filings

Bell & Lindsay, Inc.

Bell & Lindsay, Inc. filed a Q4 report for Vivos Therapeutics, Inc. on January 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Vivos Therapeutics, Inc. · Medical technology company focused on sleeping and breathing disorders.

As filed: BELL & LINDSAY, INC. for VIVOS THERAPEUTICS, INC.

All filings by Bell & Lindsay, Inc. · Everything Vivos Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Colorado

Official filing document

Lobbyists on this filing 1

MARK F LINDSAY

Previously held: Assistant to the President The White House

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

General consulting

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.